• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

FDA

psoriasis
Posted inAutoimmune Diseases, New Drugs, Regulatory

Zoryve: New Effective Cream for Psoriasis

August 1, 2022September 8, 2022

Roflumilast will cure plaque psoriasis in half of patients.

Vuity: First Pharmacological Treatment for Presbyopia
Posted inNew Drugs, Regulatory

Vuity: First Pharmacological Treatment for Presbyopia

July 29, 2022September 8, 2022

Pilocarpine by Allergan and AbbVie is the first drug for age-related farsightedness.

vitiligo
Posted inAutoimmune Diseases, New Drugs, Regulatory

Opzelura: New Treatment for Vitiligo

July 20, 2022September 8, 2022

Ruxolitinib cream will help most patients treat nonsegmental vitiligo.

Covovax/Nuvaxovid: Nanoparticle Vaccine for COVID-19
Posted inCOVID-19, Infections, New Drugs, Regulatory

Covovax/Nuvaxovid: Nanoparticle Vaccine for COVID-19

July 14, 2022September 8, 2022

Covovax/Nuvaxovid by Novavax is a protein subunit vaccine from virus-like particles.

Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus
Posted inCOVID-19, Infections, New Drugs, Regulatory

Evusheld: First Drug for Strong and Long-Lasting Protection Against Coronavirus

June 8, 2022September 8, 2022

One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.

Talicia: Highly Effective Eradication Regimen for Helicobacter pylori
Posted inInfections, New Drugs, Oncology, Regulatory

Talicia: Highly Effective Eradication Regimen for Helicobacter pylori

June 5, 2022September 8, 2022

Combination drug invented by RedHill Biopharma will get rid of Helicobacter pylori infection in 90% of patients.

Monkeypox 2022. Full Review
Posted inInfections, Research

Monkeypox 2022. Full Review

June 1, 2022September 12, 2022

Monkeypox as a new threat to humanity.

Posts navigation

Newer posts 1 2 3 4 … 10 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News